Deprescribing: is the law on your side?

Area of Science:

• Medical Law
• Pharmacology
• Patient Safety

Background:

• Deprescribing, the process of reducing or stopping medications, can be perceived as legally risky by prescribers, especially when guidelines recommend medication use.
• Polypharmacy is common, increasing the potential for adverse drug events and interactions.
• Patient-centered deprescribing offers a valuable opportunity to improve outcomes by minimizing side effects.

Purpose of the Study:

• To provide reassurance and guidance for healthcare professionals on safely deprescribing medications.
• To explore the legal implications of deprescribing, focusing on clinical negligence and informed consent.
• To examine how recent legal changes and prescribing tools can support safe deprescribing practices.

Main Methods:

• Review of UK case law related to clinical negligence and informed consent in medication withdrawal.
• Analysis of legal tests for establishing negligence and lack of informed consent.
• Discussion of prescribing tools and patient-centered approaches in deprescribing.

Main Results:

• UK case law indicates that legal barriers to deprescribing are minimal when undertaken with informed patient consent and in partnership with patients.
• Recent legal reforms emphasize the importance of providing information material to individual patient circumstances.
• Prescribing tools and collaborative decision-making enhance the safety and legality of deprescribing.

Conclusions:

• Deprescribing, when conducted collaboratively with patients and supported by clinical judgment and evidence, is legally sound.
• Informed patient consent and consideration of individual patient values are crucial for safe and legally defensible deprescribing.
• The law does not present barriers to deprescribing when it is a shared decision-making process based on patient well-being and evidence.